Blood Journals Portfolio/LinkedIn
Sep 8, 2025, 03:48
Blood Podcast Alert: Voxelotor Drops, Pediatric SCD, Thrombosis in VEXAS Syndrome and TKIs in ALL
Blood Journals Portfolio shared on LinkedIn:
”September is Sickle Cell Disease Awareness Month and together we are working to conquer SCD!
Effects of voxelotor on cerebral blood flow in pediatric sickle cell disease; thrombosis in Vexas syndrome; response to tyrosine kinase inhibitors in ABL-class acute lymphoblastic leukemia describes how voxelotor is raising hemoglobin.
Highlights are:
- Kids + sickle cell + voxelotor: Imagine your kid’s brain saying “thanks” while your hemoglobin goes up, up, up. Voxelotor drops cerebral blood flow and oxygen extraction to more normal levels—like a spa retreat for tiny brains in crisis.
- VEXAS syndrome, meet your match: Thrombosis stages its dramatic entrance—because immune dashboards love throwing plot twists.
- ABL-class ALL hitting back: Tyrosine kinase inhibitors show they still remember their moves—clocking responses like a perfect encore.
Listen to the full episode here.”
Stay tuned for the podcast series in hematology with Hemostasis Today.
-
Aug 12, 2026, 10:58Raed Ahmed: New Insights into Severe Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease
-
Aug 12, 2026, 10:27Cliff Oguk: Designing Health AI Around Real-World Clinical Needs
-
Aug 12, 2026, 09:51Orlando Agrippa: Why Promising Sickle Cell Therapies Continue to Fall Short
-
Aug 12, 2026, 09:34Tiffany Hall: Why Hemoglobin Alone Is Not Enough Before Cardiac Surgery
-
Aug 12, 2026, 08:33Craig Clapper: What the Andrea Doria Collision Teaches Us About Safety
-
Aug 12, 2026, 08:16Chengyong Yang: Can Plasma Reveal Cell Specific Signals
-
Aug 12, 2026, 07:49Alan Dursun: Phnom Penh, Cambodia – Part 3 – Turning Partnership into Action
-
Aug 12, 2026, 06:55Alejandro González Veliz: A Good PCI is not Just about Opening the Artery
-
Aug 12, 2026, 06:39Abdulmalik Alnuqydan: Why Do We Transfuse RBCs Less Than 7 Days Old to Newborns?